Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIB vs ESPB for Analgesia in Reduction Mammoplasty
NCT06225895Completed
- Sponsor
- Zagazig University
- Start
- Feb 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain (3 arms), sponsored by Zagazig University. Primary endpoints: Time to first dose of rescue analgesia and Total nalbuphine consumption. Started Feb 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06225895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06225895.